MoonLake Immunotherapeutics Peer Comparison
Metric | Value | Ranking | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $2.8 Billion | 4/13 | CERE $8.2B |
NUVL $5.8B |
ACLX $3.4B |
MLTX $2.8B |
TVTX $2.1B |
ETNB $1.6B |
DAWN $1.2B |
CMPX $516.0M |
TERN $368.6M |
PLRX $165.5M |
VTYX $114.6M |
ABOS $82.3M |
AVTE $70.7M |
Gross Margin | 0% | 4/13 | ACLX 100% |
DAWN 92% |
TVTX 80% |
MLTX 0% |
ETNB 0% |
PLRX 0% |
CERE 0% |
AVTE 0% |
CMPX 0% |
TERN 0% |
NUVL 0% |
ABOS 0% |
VTYX 0% |
Profit Margin | 0% | 2/13 | DAWN 100% |
MLTX 0% |
ETNB 0% |
PLRX 0% |
CERE 0% |
AVTE 0% |
CMPX 0% |
TERN 0% |
NUVL 0% |
ABOS 0% |
VTYX 0% |
TVTX -87% |
ACLX -99% |
EBITDA margin | -100% | 3/13 | DAWN 148% |
TVTX -87% |
MLTX -100% |
ETNB -100% |
PLRX -100% |
CERE -100% |
AVTE -100% |
CMPX -100% |
TERN -100% |
NUVL -100% |
ABOS -100% |
VTYX -100% |
ACLX -129% |
Quarterly Revenue | $0 | 4/13 | TVTX $62.9M |
ACLX $26.0M |
DAWN $20.1M |
MLTX $0 |
ETNB $0 |
PLRX $0 |
CERE $0 |
AVTE $0 |
CMPX $0 |
TERN $0 |
NUVL $0 |
ABOS $0 |
VTYX $0 |
Quarterly Earnings | -$35.9 Million | 8/13 | DAWN $37.0M |
CMPX -$10.5M |
AVTE -$16.2M |
TERN -$21.9M |
ACLX -$25.9M |
ABOS -$29.8M |
VTYX -$35.2M |
MLTX -$35.9M |
TVTX -$54.8M |
PLRX -$57.8M |
NUVL -$84.3M |
CERE -$131.9M |
ETNB -$149.1M |
Quarterly Free Cash Flow | -$25.4 Million | 8/13 | ACLX $28.4M |
DAWN -$5.0M |
CMPX -$11.1M |
AVTE -$16.0M |
TERN -$16.5M |
TVTX -$23.8M |
ABOS -$24.6M |
MLTX -$25.4M |
PLRX -$33.2M |
VTYX -$35.5M |
NUVL -$45.8M |
CERE -$119.9M |
ETNB -$145.4M |
Trailing 4 Quarters Revenue | $19,738 | 6/13 | TVTX $203.4M |
ACLX $155.8M |
DAWN $28.8M |
PLRX $4.8M |
CMPX $3.7M |
MLTX $19,738 |
ETNB $0 |
CERE $0 |
AVTE $0 |
TERN $0 |
NUVL $0 |
ABOS $0 |
VTYX $0 |
Trailing 4 Quarters Earnings | -$43.9 Billion | 13/13 | TVTX $62.9M |
ACLX $26.0M |
DAWN $20.1M |
MLTX -$0 |
ETNB -$0 |
PLRX -$0 |
CERE -$0 |
AVTE -$0 |
CMPX -$0 |
TERN -$0 |
NUVL -$0 |
ABOS -$0 |
VTYX -$0 |
Quarterly Earnings Growth | -281% | 12/13 | DAWN 180% |
VTYX 35% |
ACLX 34% |
TERN 26% |
AVTE 17% |
CMPX -5% |
CERE -26% |
PLRX -39% |
ABOS -130% |
TVTX -136% |
NUVL -151% |
MLTX -281% |
ETNB -329% |
Annual Earnings Growth | -110161% | 13/13 | ACLX 63% |
VTYX 51% |
DAWN 50% |
TERN -6% |
CMPX -9% |
AVTE -10% |
CERE -20% |
PLRX -28% |
ABOS -71% |
NUVL -85% |
ETNB -93% |
TVTX -231% |
MLTX -110161% |
Quarterly Revenue Growth | 0% | 3/13 | ACLX 74% |
TVTX 70% |
MLTX 0% |
ETNB 0% |
PLRX 0% |
CERE 0% |
AVTE 0% |
CMPX 0% |
TERN 0% |
NUVL 0% |
DAWN 0% |
ABOS 0% |
VTYX 0% |
Annual Revenue Growth | 0% | 3/13 | PLRX 551% |
ACLX 169% |
MLTX 0% |
ETNB 0% |
CERE 0% |
AVTE 0% |
CMPX 0% |
TERN 0% |
NUVL 0% |
DAWN 0% |
ABOS 0% |
VTYX 0% |
TVTX -6% |
Cash On Hand | $375.7 Million | 2/13 | DAWN $422.8M |
MLTX $375.7M |
NUVL $369.2M |
CERE $320.4M |
TERN $270.1M |
ACLX $161.8M |
ETNB $91.4M |
PLRX $79.6M |
VTYX $61.8M |
CMPX $36.8M |
TVTX $36.4M |
ABOS $33.2M |
AVTE $31.1M |
Short Term Debt | $1.4 Million | 4/13 | TVTX $73.9M |
ACLX $18.1M |
CERE $3.5M |
MLTX $1.4M |
VTYX $1.0M |
ETNB $743,000 |
CMPX $557,000 |
AVTE $459,000 |
PLRX $322,000 |
TERN $272,000 |
ABOS $129,000 |
DAWN $77,000 |
NUVL -$0 |
Long Term Debt | $1.9 Million | 9/13 | CERE $364.8M |
TVTX $328.5M |
PLRX $59.9M |
ACLX $47.2M |
ABOS $29.9M |
VTYX $10.0M |
CMPX $6.3M |
DAWN $2.5M |
MLTX $1.9M |
ETNB $1.3M |
TERN $1.0M |
AVTE $81,000 |
NUVL $0 |
PE | -1.00 | 1/13 | MLTX -1.00 |
ETNB -1.00 |
PLRX -1.00 |
CERE -1.00 |
AVTE -1.00 |
CMPX -1.00 |
TVTX -1.00 |
TERN -1.00 |
NUVL -1.00 |
DAWN -1.00 |
ABOS -1.00 |
ACLX -1.00 |
VTYX -1.00 |
PS | 141444.87 | 1/13 | MLTX 141444.87 |
CMPX 139.67 |
DAWN 42.44 |
PLRX 34.20 |
ACLX 21.97 |
TVTX 10.16 |
ETNB -1.00 |
CERE -1.00 |
AVTE -1.00 |
TERN -1.00 |
NUVL -1.00 |
ABOS -1.00 |
VTYX -1.00 |
PB | 5.63 | 3/13 | CERE 14.51 |
ACLX 7.09 |
MLTX 5.63 |
NUVL 5.15 |
ETNB 4.24 |
CMPX 3.73 |
DAWN 2.20 |
TERN 1.01 |
AVTE 0.88 |
PLRX 0.48 |
VTYX 0.41 |
ABOS 0.38 |
TVTX 0.00 |
PC | 7.43 | 7/13 | TVTX 56.77 |
CERE 25.56 |
ACLX 21.16 |
ETNB 17.55 |
NUVL 15.63 |
CMPX 14.02 |
MLTX 7.43 |
DAWN 2.89 |
ABOS 2.48 |
AVTE 2.27 |
PLRX 2.08 |
VTYX 1.85 |
TERN 1.36 |
Liabilities to Equity | 0.05 | 11/13 | CERE 1.00 |
ACLX 0.58 |
PLRX 0.29 |
ABOS 0.23 |
ETNB 0.21 |
AVTE 0.13 |
CMPX 0.08 |
DAWN 0.08 |
VTYX 0.08 |
NUVL 0.06 |
MLTX 0.05 |
TERN 0.04 |
TVTX 0.00 |
ROA | -84.78 | 13/13 | ACLX -5% | DAWN -15% | NUVL -19% | TERN -23% | ABOS -31% | CMPX -32% | VTYX -35% | CERE -41% | PLRX -47% | ETNB -63% | TVTX -70% | AVTE -93% | MLTX -8478% |
ROE | -89.99 | 13/13 | TVTX 1154% |
ACLX -8% |
DAWN -16% |
NUVL -20% |
TERN -24% |
CMPX -35% |
ABOS -38% |
VTYX -38% |
PLRX -61% |
ETNB -76% |
CERE -82% |
AVTE -105% |
MLTX -8999% |
Current Ratio | 22.82 | 2/13 | TERN 27.48 |
MLTX 22.82 |
NUVL 17.55 |
CMPX 13.87 |
VTYX 13.49 |
DAWN 13.25 |
AVTE 8.69 |
ETNB 5.71 |
ABOS 5.36 |
PLRX 4.46 |
ACLX 2.71 |
CERE 2.00 |
TVTX 0.94 |
Quick Ratio | 21.75 | 2/13 | MLTX -1.00 |
ETNB -1.00 |
PLRX -1.00 |
CERE -1.00 |
AVTE -1.00 |
CMPX -1.00 |
TVTX -1.00 |
TERN -1.00 |
NUVL -1.00 |
DAWN -1.00 |
ABOS -1.00 |
ACLX -1.00 |
VTYX -1.00 |
Long Term Debt to Equity | 0.00 | 7/13 | CERE} 0.65 |
PLRX} 0.17 |
ABOS} 0.14 |
ACLX} 0.10 |
CMPX} 0.05 |
VTYX} 0.04 |
MLTX} 0.00 |
ETNB} 0.00 |
AVTE} 0.00 |
TERN} 0.00 |
NUVL} 0.00 |
DAWN} 0.00 |
TVTX} -10.79 |
Debt to Equity | 0.01 | 7/13 | CERE 0.65 |
PLRX 0.17 |
ABOS 0.14 |
ACLX 0.14 |
CMPX 0.05 |
VTYX 0.04 |
MLTX 0.01 |
ETNB 0.01 |
AVTE 0.01 |
TERN 0.00 |
NUVL 0.00 |
DAWN 0.00 |
TVTX -13.21 |
Burn Rate | 10.33 | 2/13 | TERN 12.25 |
MLTX 10.33 |
ACLX 5.01 |
NUVL 4.38 |
CMPX 3.38 |
CERE 2.17 |
AVTE 1.90 |
VTYX 1.72 |
PLRX 1.32 |
ABOS 1.07 |
ETNB 0.61 |
TVTX 0.42 |
DAWN -11.45 |
Cash to Cap | 0.13 | 7/13 | TERN 0.73 |
VTYX 0.54 |
PLRX 0.48 |
AVTE 0.44 |
ABOS 0.40 |
DAWN 0.35 |
MLTX 0.13 |
CMPX 0.07 |
ETNB 0.06 |
NUVL 0.06 |
ACLX 0.05 |
CERE 0.04 |
TVTX 0.02 |
CCR | 0.71 | 8/13 | CMPX 1.06 |
VTYX 1.01 |
AVTE 0.99 |
ETNB 0.98 |
CERE 0.91 |
ABOS 0.83 |
TERN 0.75 |
MLTX 0.71 |
PLRX 0.57 |
NUVL 0.54 |
TVTX 0.43 |
DAWN -0.13 |
ACLX -1.10 |
EV to EBITDA | -67.17 | 12/13 | DAWN} 27.10 |
ETNB} -1.00 |
CERE} -1.00 |
AVTE} -1.00 |
TERN} -1.00 |
NUVL} -1.00 |
ABOS} -1.00 |
VTYX} -1.00 |
PLRX} -2.36 |
CMPX} -41.28 |
TVTX} -44.44 |
MLTX} -67.17 |
ACLX} -98.99 |
EV to Revenue | 122584.01 | 1/13 | MLTX 122584.01 |
CMPX 131.57 |
PLRX 30.19 |
DAWN 27.86 |
ACLX 21.36 |
TVTX 11.96 |
ETNB -1.00 |
CERE -1.00 |
AVTE -1.00 |
TERN -1.00 |
NUVL -1.00 |
ABOS -1.00 |
VTYX -1.00 |